Cosmos Health Inc. (COSM) vs TScan Therapeutics, Inc. (TCRX)

A side-by-side comparison of Cosmos Health Inc. and TScan Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COSM vs TCRX

growth of $100 · dividends reinvested · last 5y
COSM -99.7% (-69.0%/yr)TCRX -97.2% (-51.0%/yr)TCRX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$0$3
COSM TCRX

COSM vs TCRX: by the numbers

  • •COSM is the larger company ($18M vs $17M market cap).
  • •Both run net losses; COSM's is the smaller (-33.08% vs -1655.35% net margin).
  • •COSM grew revenue faster over the past five years (5.24% vs 3.60% CAGR).

Metrics side by side

Valuation

MetricCOSMTCRX
P/S ratio0.242.33
P/B ratio0.860.24

Profitability

MetricCOSMTCRX
Gross margin10.27%72.24%
Operating margin-24.65%-1315.38%
Net margin-33.08%-1655.35%
ROE-117.98%-170.55%
ROIC-46.69%-79.20%

Growth (annualized)

MetricCOSMTCRX
Revenue CAGR (5Y)5.24%3.60%
Total return CAGR (5Y)-68.41%-48.85%

Frequently asked

Which has grown faster, COSM or TCRX?
Over the past five years, COSM grew revenue faster — COSM at a 5.24% CAGR versus TCRX at 3.60%.
How have COSM and TCRX total returns compared?
Over the past 5 years, COSM delivered -68.41% and TCRX delivered -48.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.